about
Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis.Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controlsPrevalence and Patterns of Multi-Morbidity in Serbian Adults: A Cross-Sectional Study.Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary diseaseDoes urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.COPD updates: what's new in pathophysiology and management?A practical approach to radiological evaluation of CT lung cancer screening examinations.Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.Factors associated with inpatient readmission among managed care enrollees with COPD.Oxidative and proteolysis-related parameters of skeletal muscle from hamsters with experimental pulmonary emphysema: a comparison between papain and elastase induction.Assessment of energy intake in women with chronic obstructive pulmonary disease: a doubly labeled water method study.B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.Application of a modified gaseous exposure system to the in vitro toxicological assessment of tobacco smoke toxicants.Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.The association of low bone mineral density with systemic inflammation in clinically stable COPD.Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPDThe Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
P2860
Q23910517-FB1A0EA1-5B73-4426-9B47-E5451BB9A71DQ26781677-1D451C6E-ECFB-476E-8C8D-E53B8D68D729Q33669505-A5A2413A-FF08-4223-853C-83BCE41CBD5DQ35042664-85EE50C8-E0B2-4596-84D0-03708BF850CBQ35922311-8DFFB806-12AC-4550-9B9F-1D11C4AF6F77Q36071793-F6A3B87B-B19A-4309-AE02-1E60CAC14920Q36628196-17AFDA85-5238-455E-86C9-346583816B6DQ37702279-76CA659B-2339-4EEF-96C8-E768287B104DQ38056532-F3A8CB32-9B12-46FF-A553-1667A1CFE990Q38066244-B3684099-D1C2-4AE3-9FE7-11FD38CC82D5Q38130515-6806083B-5710-4B0D-BB3B-29532592E454Q38141718-6561B008-4EC8-4EEF-AA0A-C70BB647D0A9Q38192501-C82761D3-BA29-4B23-BD6B-2FFF18EE1F9DQ39213247-3110F7BB-5D60-45F1-9A18-1DA32B438845Q40552194-67CB6B80-0552-400F-B3A2-EF232DC0D5FDQ40808876-23F65680-4CD4-413E-A26E-90639B4B51CBQ40999794-DF4EC400-0F8A-4A53-9920-EBEE8BD721A9Q41632240-819A74F2-E136-43E5-A5C4-4A9CBC80423EQ46738415-B34A336C-5BEB-4A11-8127-0487BE28E828Q48681818-8909A1C4-A525-40E1-8470-B15E4982D875Q49996978-B6298E54-EFF5-43B8-ACC3-15B0BF8CB74EQ51296469-D3794F5E-31E5-4291-854F-2D008F7BC2DFQ51373002-507A2A86-FAFE-4026-A367-38FEB17D72FCQ51431426-EF67A114-364F-4C07-899C-7D2555E95546Q51599339-24A7E30A-8775-421D-8106-B9B17B00CC8FQ55232881-C67221CB-2184-4B20-9D04-5AC677D85ACFQ57817669-4D221AAB-C589-4D6D-B9D1-0EAC9ABB2F9EQ59130095-2BBC2E76-DDF5-47C8-BE80-59FAC35D998F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
COPD: a multifactorial systemic disease.
@en
COPD: a multifactorial systemic disease.
@nl
type
label
COPD: a multifactorial systemic disease.
@en
COPD: a multifactorial systemic disease.
@nl
prefLabel
COPD: a multifactorial systemic disease.
@en
COPD: a multifactorial systemic disease.
@nl
P2860
P356
P1476
COPD: a multifactorial systemic disease.
@en
P2093
Paolo Palange
P2860
P304
P356
10.1177/1753465811400490
P577
2011-03-23T00:00:00Z